NCT03119610: The Physiologic Effects of Intranasal Oxytocin on Sarcopenic Obesity
- State
- Completed
- Phase
- Phase 1 and Phase 2
- People
- 23 taking part
- Started
- 22 Sep 2017
- Primary completion
- 17 Dec 2018
- Arms
- Placebo nasal spray
- Results
- Posted on the registry
- Papers
- doi:10.1016/j.jamda.2021.04.015
- 18 Apr 2017: Trial registered
- 22 Sep 2017: Trial started
- 17 Dec 2019: Trial completed
- 22 Oct 2020: Trial results posted